GSDMB and central nervous system cancer: CASP1 displayed the highest mutation frequency, followed by Gasdermin C (GSDMC), while CASP3, Gasdermin B (GSDMB), Gasdermin E (GSDME), and GZAMB did not display any mutations in glioma samples (Figure 1D).